Clinical trial
Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey
NCT00660712 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2008
- Completion date
- March 31, 2009
- Enrollment
- 1,018 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.